EUVIMEDEUVIMED entdecken
Crossref

Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells

Atefeh Sharifhoseini, Masoud Heshmati, Amin Soltani, Mahshad Entezam, Hedayatollah Shirzad, Morteza Sedehi, Babri A Judd, Mohammad-Saeid Jami, Mahdi Ghatrehsamani

Molecular Biology Reports · 2023

DOI: 10.1007/s11033-023-08718-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2023. Verfasst von Atefeh Sharifhoseini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, PO Box: 88155-571, Shahrekord, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Interleukin-6. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Shahrekord University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bromodomain and extra-terminal (BET) proteins are recognized acetylated lysine of histone 4 and act as scaffolds to recruit many other proteins to promoters and enhancers of active genes, especially at the super-enhancers of key genes, driving the transcription process and have been identified as potential therapeutic targets in breast cancer. However, the efficacy of BET inhibitors such as JQ1 in breast cancer therapy is impeded by interleukin-6 (IL-6) through an as-yet-defined mechanism. METHODS AND RESULTS: We investigated the interplay between IL-6 and JQ1 in MCF-7 and MDA-MB-231 human breast cancer cells. The results demonstrate that the efficacy of JQ1 on the inhibition of cell growth and apoptosis was stronger in MDA-MB-231 cells than in MCF-7 cells. Further, MCF-7 cells, but not MDA-MB-231 cells, exhibited increased expression of CXCR4 following IL-6 treatment. JQ1 significantly reduced CXCR4 surface expression in both cell lines and diminished the effects of IL-6 pre-treatment on MCF-7 cells. While IL-6 suppressed the extension of breast cancer stem cells in MCF-7 cells, JQ1 impeded its inhibitory effect. In MCF-7 cells JQ1 increased the number of senescent cells in a time-dependent manner. CONCLUSION: Analysis of gene expression indicated that JQ1 and IL-6 synergistically increase SNAIL expression and decrease c-MYC expression in MCF-7 cells. So, the BET proteins are promising, novel therapeutic targets in late-stage breast cancers. BET inhibitors similar to JQ1 show promise as therapeutic candidates for breast cancers, especially when triple-negative breast cancer cells are increased and/or tumor-promoting factors like IL-6 exist in the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsInterleukin-6FemaleHumansCell Line, TumorCell ProliferationMCF-7 CellsProto-Oncogene Proteins c-mycSignal TransductionTumor MicroenvironmentAzepinesTriazoles

Stichwörter der Autor:innen

BET inhibitorBreast cancerBreast cancer stem cellCXCR4IL-6JQ1

Substanzen

Interleukin-6Proto-Oncogene Proteins c-myc(+)-JQ1 compoundAzepinesTriazoles

Autor:innen und Institutionen

  • Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, PO Box: 88155-571, Shahrekord, Iran.
  • Department of Microbiology and Immunology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Department of Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Immunology Science Editors, Eden Prairie, MN, USA.
  • Department of Neurology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, PO Box: 88155-571, Shahrekord, Iran. mahdi.samani.2020@gmail.com.

Förderung

  • Shahrekord University of Medical Sciences

Zitieren

APA

Sharifhoseini, A., Heshmati, M., Soltani, A., Entezam, M., Shirzad, H., Sedehi, M., Judd, B. A., Jami, M. S., & Ghatrehsamani, M. (2023). Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells. Molecular Biology Reports. https://doi.org/10.1007/s11033-023-08718-5

Vancouver

Sharifhoseini A, Heshmati M, Soltani A, Entezam M, Shirzad H, Sedehi M, et al. Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells. Molecular Biology Reports. 2023. doi:10.1007/s11033-023-08718-5

BibTeX
@article{Sharifhoseini2023,
  author = {Sharifhoseini, Atefeh and Heshmati, Masoud and Soltani, Amin and Entezam, Mahshad and Shirzad, Hedayatollah and Sedehi, Morteza and Judd, Babri A and Jami, Mohammad-Saeid and Ghatrehsamani, Mahdi},
  title = {Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells},
  journal = {Molecular Biology Reports},
  year = {2023},
  doi = {10.1007/s11033-023-08718-5}
}
Kostenlos starten →